Comparison of the pharmacokinetics and pharmacodynamics of once daily tiotropium Respimat® and tiotropium HandiHaler® in COPD patients
A. Sharma, J. Hohlfeld, P. Cornelissen, J. van Noord, E. Derom, L. Towse, V. Peterkin, B. Disse (Biberach, Hannover, Ingelheim, Germany; Alkmaar, Heerlen, Netherlands; Ghent, Belgium; Bracknell, United Kingdom)
Source: Annual Congress 2013 –LAMA, LABA, ICS and their combinations for the treatment of asthma and COPD
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
A. Sharma, J. Hohlfeld, P. Cornelissen, J. van Noord, E. Derom, L. Towse, V. Peterkin, B. Disse (Biberach, Hannover, Ingelheim, Germany; Alkmaar, Heerlen, Netherlands; Ghent, Belgium; Bracknell, United Kingdom). Comparison of the pharmacokinetics and pharmacodynamics of once daily tiotropium Respimat® and tiotropium HandiHaler® in COPD patients. Eur Respir J 2013; 42: Suppl. 57, 4631
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: